Viral Pneumonia

Liver Cirrhosis Patients With Invasive Pulmonary Aspergillosis: in Depth Understanding Clinical Host Risk Factors

Investigation of the Effects of Oxidized Antigens on the T-Cell Response and the Epigenetic Reprogramming of Neutrophils in Lung Diseases - OXIGENE -

Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral Infection

Efficacy and Safety of Trimodulin (BT588) in Subjects With CAP Including COVID-19 Pneumonia

Mucosal Associated Invariant T Cell During Viral Pneumonia and Acute Respiratory Distress Syndrome

Multiplex PCR for Severe Respiratory Infections During the COVID-19 Pandemic

Mesenchymal Stromal Cells for COVID-19 and Viral Pneumonias

PTH - Preemptive Treatment for Herpesviridae

Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection

Imaging Feature of SARS-CoV2 Infection

Inhaled NO for the Treatment of Viral Pneumonia in Adults

Yinhu Qingwen Granule in the Treatment of Viral Pneumonia

Discover the Immune Signature of Sepsis Caused by Acute Pulmonary Infection: A Cohort Study

Efficacy and Safety of Novel Treatment Options for Adults With COVID-19 Pneumonia

Study of the Use of the Drug Ingaron in Patients With COVID-19

Circulatory Coherence in COVID-19 and Non-COVID-19 Patients With Sepsis

Clinical, Molecular and Functional Biomarkers for PROgnosis, Pathomechanisms and Treatment Strategies of COVID-19 (PROVID) - (PROVID-CAPNETZ)

Pilot Study for Cyproheptadine in Hospitalized Patient for COVID-19

Cyproheptadine in Severe COVID-19 : A Unblinded Randomized Trial

Mavrilimumab in Severe COVID-19 Pneumonia and Hyper-inflammation (COMBAT-19)